254 research outputs found

    Harlequin Ichthyosis: a rare congenital dermatological disorder

    Get PDF
    Harlequin Ichthyosis is the most severe form of congenital Ichthyosis presenting at birth. It is a very rare disorder with autosomal recessive inheritance. Perinatal mortality is high and the survivors develop severe erythroderma subsequently. We report a case of Harlequin Ichthyosis not only because of its rarity but also its tendency to occur in consecutive pregnancies

    Development of sunlight-driven eutectic phase change material nanocomposite for applications in solar water heating

    Get PDF
    Organic phase change materials (PCMs) have been utilized as latent heat energy storage medium for effective thermal management. In this work, a PCM nanocomposite, consisting of a mixture of two organic PCMs (referred to as eutectic gel PCM) and minimal amount (0.5 wt%) of nanographite (NG) as a supporting material, was prepared. Differential scanning calorimeter was used to determine the melting temperature and latent heat of pristine PCM, paraffin (61.5 °C and 161.5 J/g), eutectic gel PCM (54 °C and 158 J/g) and eutectic gel PCM nanocomposite (53.5 °C and 155 J/g). The prepared PCM nanocomposites exhibited enhanced thermal conductivity and ultrafast thermal charging characteristics. The nanocomposites were employed for two different applications: (i) providing hot water using an indigenously fabricated solar water heating (SWH) system and (ii) solar rechargeable glove that can be rapidly warmed and used. Experimental results on SWH system show that the use of PCM nanocomposites helps to increase the charging rate of PCM while reducing the discharging rate of heat by PCM to water, thus enhancing the maximum utilization of solar energy and hence improving the efficiency of the SWH system. The experimental results on solar rechargeable glove revealed that the glove has the ability to retain the temperature up to 3 hours

    Evaluation of standardization parameter of polyherbal digestive “churna”

    Get PDF
    The development in these traditional systems of medicine leads to maintain proper quality of the product. India is rich in its flora and fauna. These plants are being used for curing many diseases as such in raw condition rather the being prepared as formulation. Churana is defined as a fine powder of drug or drugs in Ayurvedic system of medicine. Drugs mentioned in patha, are cleaned properly, dried thoroughly, pulverised and then sieved. The churana is free flowing and retains its potency for one year, if preserved in air tight containers. Churna formulations are similar to powder formulations in Allopathic system of medicine. In recent days churna is formulated into tablets in order to fix the dose easily. The churana was evaluated depending on various evaluation parameters and from the results obtained it was found to be within the standards. These preliminary tests can be prescribed as standards to fix the quality control test the churana and can be used in routine analysis of the same. The can also be used to perform quality control and quality assurance in the laboratory

    Surface Wear Studies in Some Materials Using α-induced Reactions

    Get PDF
    The radio-activity produced during the irradiation of 63,65Cu, 59Co, 93Nb and 121,123Sb targets with α-particles have been measured using activation technique. he yields of radioactive isotopic products 66,67,68 Ga, 61 Cu, 96g,mTc and 123,124,126I have been determined in the energy range ≈ 10-40 MeV using stacked foil Technique. Radioactive counting of samples was performed with a high-resolution gamma-spectrometer. As light ion beams produce an extremely narrow layer of activities in the surface of a material, these reactions may be useful for thin layer activation study

    The sensitivity of qSOFA calculated at triage and during emergency department treatment to rapidly identify sepsis patients.

    Get PDF
    The quick sequential organ failure assessment (qSOFA) score has been proposed as a means to rapidly identify adult patients with suspected infection, in pre-hospital, Emergency Department (ED), or general hospital ward locations, who are in a high-risk category with increased likelihood of poor outcomes: a greater than 10% chance of dying or an increased likelihood of spending 3 or more days in the ICU. This score is intended to replace the use of systemic inflammatory response syndrome (SIRS) criteria as a screening tool; however, its role in ED screening and identification has yet to be fully elucidated. In this retrospective observational study, we explored the performance of triage qSOFA (tqSOFA), maximum qSOFA, and first initial serum lactate (\u3e 3 mmol/L) at predicting in-hospital mortality and compared these results to those for the initial SIRS criteria obtained in triage. A total of 2859 sepsis cases were included and the in-hospital mortality rate was 14.4%. The sensitivity of tqSOFA ≥ 2 and maximum qSOFA ≥ 2 to predict in-hospital mortality were 33% and 69%, respectively. For comparison, the triage SIRS criteria and the initial lactate \u3e 3 mmol/L had sensitivities of 82% and 65%, respectively. These results demonstrate that in a large ED sepsis database the earliest measurement of end organ impairment, tqSOFA, performed poorly at identifying patients at increased risk of mortality and maximum qSOFA did not significantly outperform initial serum lactate levels

    The Tpeak – Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: a systematic review and meta-analysis

    Get PDF
    Background: The Tpeak – Tend interval, an electrocardiographic marker reflecting transmural dispersion of repolarization, has been used to predict ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac death (SCD) in different clinical settings. Objective: This systematic review and meta-analysis evaluated the significance of Tpeak – Tend interval in predicting arrhythmic and/or mortality endpoints. Methods: PubMed, Embase, Cochrane Library and CINAHL Plus databases were searched through 30th November 2016.Results: Of the 854 studies identified initially, 33 observational studies involving 155856 patients were included in our meta-analysis. Tpeak – Tend interval prolongation (mean cut-off: 103.3 ± 17.4 ms) was a significant predictor of the arrhythmic or mortality outcomes (odds ratio (OR): 1.14, 95% CI: 1.11 to 1.17, p < 0.001). When different end-points were analyzed, the ORs are as follows: VT/VF (1.10, 95% CI: 1.06 to 1.13, p < 0.0001), SCD (1.27, 95% CI 1.17 to 1.39, p < 0.0001), cardiovascular death (1.40, 95% CI 1.19 to 1.64, p < 0.0001), and all-cause mortality (4.56, 95% CI 0.62 to 33.68, p < 0.0001). Subgroup analysis for each disease revealed that the risk of VT/VF or death was highest for Brugada syndrome (OR: 5.68, 95% CI: 1.57 to 20.53, p < 0.01), followed by hypertension (OR: 1.52, 95% CI: 1.26 to 1.85, p < .0001), heart failure (OR: 1.07, 95% CI: 1.04 to 1.11, p < .0001) and ischemic heart disease (OR: 1.06, 95% CI: 1.02 to 1.10, p = 0.001). In the general population, a prolonged Tpeak – Tend interval also predicted arrhythmic or mortality outcomes (OR: 1.59, 95% CI: 1.21 to 2.09, p < 0.001).Conclusion: The Tpeak – Tend interval is useful risk stratification tool in different diseases and in the general population

    The Eleventh and Twelfth Data Releases of the Sloan Digital Sky Survey: Final Data from SDSS-III

    Get PDF
    The third generation of the Sloan Digital Sky Survey (SDSS-III) took data from 2008 to 2014 using the original SDSS wide-field imager, the original and an upgraded multi-object fiber-fed optical spectrograph, a new near-infrared high-resolution spectrograph, and a novel optical interferometer. All of the data from SDSS-III are now made public. In particular, this paper describes Data Release 11 (DR11) including all data acquired through 2013 July, and Data Release 12 (DR12) adding data acquired through 2014 July (including all data included in previous data releases), marking the end of SDSS-III observing. Relative to our previous public release (DR10), DR12 adds one million new spectra of galaxies and quasars from the Baryon Oscillation Spectroscopic Survey (BOSS) over an additional 3000 deg2 of sky, more than triples the number of H-band spectra of stars as part of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE), and includes repeated accurate radial velocity measurements of 5500 stars from the Multi-object APO Radial Velocity Exoplanet Large-area Survey (MARVELS). The APOGEE outputs now include the measured abundances of 15 different elements for each star. In total, SDSS-III added 5200 deg2 of ugriz imaging; 155,520 spectra of 138,099 stars as part of the Sloan Exploration of Galactic Understanding and Evolution 2 (SEGUE-2) survey; 2,497,484 BOSS spectra of 1,372,737 galaxies, 294,512 quasars, and 247,216 stars over 9376 deg2; 618,080 APOGEE spectra of 156,593 stars; and 197,040 MARVELS spectra of 5513 stars. Since its first light in 1998, SDSS has imaged over 1/3 of the Celestial sphere in five bands and obtained over five million astronomical spectra. \ua9 2015. The American Astronomical Society

    Federated learning enables big data for rare cancer boundary detection.

    Get PDF
    Although machine learning (ML) has shown promise across disciplines, out-of-sample generalizability is concerning. This is currently addressed by sharing multi-site data, but such centralization is challenging/infeasible to scale due to various limitations. Federated ML (FL) provides an alternative paradigm for accurate and generalizable ML, by only sharing numerical model updates. Here we present the largest FL study to-date, involving data from 71 sites across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, reporting the largest such dataset in the literature (n = 6, 314). We demonstrate a 33% delineation improvement for the surgically targetable tumor, and 23% for the complete tumor extent, over a publicly trained model. We anticipate our study to: 1) enable more healthcare studies informed by large diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further analyses for glioblastoma by releasing our consensus model, and 3) demonstrate the FL effectiveness at such scale and task-complexity as a paradigm shift for multi-site collaborations, alleviating the need for data-sharing
    corecore